Test Bank for Clayton's Basic
Pharmacology for Nurses exam
with full solution
Terms in this set (510)
Official Name Name under which a drug is listed by FDA.
Brand Name Name given by the drug manufacturer.
Nonproprietary Name Generic name provided by USAN Council.
United States Pharmacopoeia Contains standards for nutritional supplements.
Drug Facts and Comparisons Contains monographs for all therapeutic class drugs.
AHFS Drug Information Monographs for nearly all single-entity drugs.
DailyMed Comprehensive online resource for medicines.
Drug Monographs Detailed descriptions of drugs in a class.
,Natural Medicines Comprehensive Database Evidence-based info on herbal medicines.
Drug Interaction Facts Information on drug interactions.
USP Dictionary of USAN Compilation of drug names and pronunciations.
Martindale—The Complete Drug Reference Comprehensive drug reference for various medications.
Nutritional Supplements Products intended to supplement diet.
Clinical Judgment Decision-making based on clinical data.
Patient Education Information provided to patients about medications.
Cost Indices Comparative pricing information for drugs.
Dosage Forms Forms in which drugs are available.
Therapeutic Uses Approved and unapproved uses of drugs.
Healthcare Providers Professionals who prescribe and administer medications.
Public Access Availability of drug information to general public.
Safety Considerations for preventing harm in drug use.
Physiological Integrity Maintaining bodily functions and health.
Federal Food, Drug, and Cosmetic Act Legislation authorizing FDA drug safety evaluation.
Durham Humphrey Amendment Defines prescription-only drugs requiring medical supervision.
Controlled Substances Act Regulates controlled substances and their categorization.
Kefauver Harris Drug Amendment Mandates drug efficacy proof before marketing.
Meperidine (Demerol) A Schedule II drug with high abuse potential.
Schedule I Drugs High abuse potential, no medical use recognized.
Schedule II Drugs High abuse potential, severe dependence risk.
Schedule III Drugs Moderate abuse potential, dependence risk exists.
Schedule IV Drugs Low abuse potential, limited dependence risk.
Fast Tracking Expedited FDA process for urgent drug approvals.
, Investigational New Drug Application Application for FDA approval of new drugs.
Over-the-Counter (OTC) Drugs Medications sold without a prescription.
USP NF Official compendium listing drug standards.
Health Orphan Disease Rare diseases not prioritized for research.
Preclinical Research Phase Initial phase assessing drug safety before trials.
Clinical Research Phase Testing drug efficacy and safety in humans.
Patient Education Informing patients about medications and treatments.
Clinical Judgment Decision-making based on patient assessment data.
Safety Protection against harm in healthcare settings.
Evidence Data supporting clinical practices and decisions.
Care Coordination Organizing patient care activities among providers.
Health Care Policy Guidelines governing healthcare practices and regulations.
Physiological Integrity Maintaining body functions and health stability.
Handbook on Injectable Drugs Comprehensive reference for injectable drug compatibility.
Lomotil Schedule V drug with low abuse potential.
Schedule V drugs Controlled substances with limited abuse potential.
Lortab Schedule III drug with high potential for abuse.
Diazepam Schedule IV drug with low abuse potential.
Phenobarbital Schedule IV drug, lower abuse potential than Schedule III.
Patient medication history List of current medications and prescriptions.
Martindale—The Complete Drug Reference Resource with written medication information.
Drugs and Facts Comparisons Contains drug monographs for therapeutic classes.
Senior citizens' center Not a reliable source for specific medication information.
Patient's home pharmacy Accurate account of all medications currently taken.
Generic drug names Most products marketed under these names.
Pharmacology for Nurses exam
with full solution
Terms in this set (510)
Official Name Name under which a drug is listed by FDA.
Brand Name Name given by the drug manufacturer.
Nonproprietary Name Generic name provided by USAN Council.
United States Pharmacopoeia Contains standards for nutritional supplements.
Drug Facts and Comparisons Contains monographs for all therapeutic class drugs.
AHFS Drug Information Monographs for nearly all single-entity drugs.
DailyMed Comprehensive online resource for medicines.
Drug Monographs Detailed descriptions of drugs in a class.
,Natural Medicines Comprehensive Database Evidence-based info on herbal medicines.
Drug Interaction Facts Information on drug interactions.
USP Dictionary of USAN Compilation of drug names and pronunciations.
Martindale—The Complete Drug Reference Comprehensive drug reference for various medications.
Nutritional Supplements Products intended to supplement diet.
Clinical Judgment Decision-making based on clinical data.
Patient Education Information provided to patients about medications.
Cost Indices Comparative pricing information for drugs.
Dosage Forms Forms in which drugs are available.
Therapeutic Uses Approved and unapproved uses of drugs.
Healthcare Providers Professionals who prescribe and administer medications.
Public Access Availability of drug information to general public.
Safety Considerations for preventing harm in drug use.
Physiological Integrity Maintaining bodily functions and health.
Federal Food, Drug, and Cosmetic Act Legislation authorizing FDA drug safety evaluation.
Durham Humphrey Amendment Defines prescription-only drugs requiring medical supervision.
Controlled Substances Act Regulates controlled substances and their categorization.
Kefauver Harris Drug Amendment Mandates drug efficacy proof before marketing.
Meperidine (Demerol) A Schedule II drug with high abuse potential.
Schedule I Drugs High abuse potential, no medical use recognized.
Schedule II Drugs High abuse potential, severe dependence risk.
Schedule III Drugs Moderate abuse potential, dependence risk exists.
Schedule IV Drugs Low abuse potential, limited dependence risk.
Fast Tracking Expedited FDA process for urgent drug approvals.
, Investigational New Drug Application Application for FDA approval of new drugs.
Over-the-Counter (OTC) Drugs Medications sold without a prescription.
USP NF Official compendium listing drug standards.
Health Orphan Disease Rare diseases not prioritized for research.
Preclinical Research Phase Initial phase assessing drug safety before trials.
Clinical Research Phase Testing drug efficacy and safety in humans.
Patient Education Informing patients about medications and treatments.
Clinical Judgment Decision-making based on patient assessment data.
Safety Protection against harm in healthcare settings.
Evidence Data supporting clinical practices and decisions.
Care Coordination Organizing patient care activities among providers.
Health Care Policy Guidelines governing healthcare practices and regulations.
Physiological Integrity Maintaining body functions and health stability.
Handbook on Injectable Drugs Comprehensive reference for injectable drug compatibility.
Lomotil Schedule V drug with low abuse potential.
Schedule V drugs Controlled substances with limited abuse potential.
Lortab Schedule III drug with high potential for abuse.
Diazepam Schedule IV drug with low abuse potential.
Phenobarbital Schedule IV drug, lower abuse potential than Schedule III.
Patient medication history List of current medications and prescriptions.
Martindale—The Complete Drug Reference Resource with written medication information.
Drugs and Facts Comparisons Contains drug monographs for therapeutic classes.
Senior citizens' center Not a reliable source for specific medication information.
Patient's home pharmacy Accurate account of all medications currently taken.
Generic drug names Most products marketed under these names.
